
News|Articles|December 11, 2012
Longer-duration treatment for male UTI not advantageous
When men are treated for a longer-duration antibiotic therapy for urinary tract infection (UTI), there is no decrease in early recurrence compared with those treated for a shorter duration, according to a study online in Archives of Internal Medicine.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
AI Helps Managed Care Identify High-Risk Patients Sooner and More Precisely | AMCP Nexus 2025
2
Real-World Study Shows $330,000 Cost Difference Between CAR T and BiTE Therapies | AMCP Nexus 2025
3
Real-World Data Drives CAR T Treatment Decisions, Reveals Benefits of Earlier Administration | AMCP Nexus 2025
4
Cardiovascular, Renal and Metabolic Conditions Increasingly Prevalent, Expensive in Medicare Fee-For-Service Population | AMCP Nexus 2025
5



















































